159 related articles for article (PubMed ID: 35322764)
1. Screening of novel and selective inhibitors for neuronal nitric oxide synthase (nNOS) via structure-based drug design techniques.
Boumezber S; Yelekçi K
J Biomol Struct Dyn; 2023 May; 41(8):3607-3629. PubMed ID: 35322764
[TBL] [Abstract][Full Text] [Related]
2. Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.
Silverman RB
Acc Chem Res; 2009 Mar; 42(3):439-51. PubMed ID: 19154146
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for isoform-selective inhibition in nitric oxide synthase.
Poulos TL; Li H
Acc Chem Res; 2013 Feb; 46(2):390-8. PubMed ID: 23030042
[TBL] [Abstract][Full Text] [Related]
4. Fire ant venom alkaloid, isosolenopsin A, a potent and selective inhibitor of neuronal nitric oxide synthase.
Yi GB; McClendon D; Desaiah D; Goddard J; Lister A; Moffitt J; Meer RK; deShazo R; Lee KS; Rockhold RW
Int J Toxicol; 2003; 22(2):81-6. PubMed ID: 12745988
[TBL] [Abstract][Full Text] [Related]
5. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
Hah JM; Martásek P; Roman LJ; Silverman RB
J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
[TBL] [Abstract][Full Text] [Related]
6. Structure-guided design of selective inhibitors of neuronal nitric oxide synthase.
Huang H; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2013 Apr; 56(7):3024-32. PubMed ID: 23451760
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of trans 3,4-cyclopropyl L-arginine analogues as isoform selective inhibitors of nitric oxide synthase.
Fishlock D; Perdicakis B; Montgomery HJ; Guillemette JG; Jervis E; Lajoie GA
Bioorg Med Chem; 2003 Mar; 11(6):869-73. PubMed ID: 12614872
[TBL] [Abstract][Full Text] [Related]
8. The inhibitory potency and selectivity of arginine substrate site nitric-oxide synthase inhibitors is solely determined by their affinity toward the different isoenzymes.
Boer R; Ulrich WR; Klein T; Mirau B; Haas S; Baur I
Mol Pharmacol; 2000 Nov; 58(5):1026-34. PubMed ID: 11040050
[TBL] [Abstract][Full Text] [Related]
9. Insights into the structural determinants for selective inhibition of nitric oxide synthase isoforms.
Oliveira BL; Moreira IS; Fernandes PA; Ramos MJ; Santos I; Correia JD
J Mol Model; 2013 Apr; 19(4):1537-51. PubMed ID: 23263357
[TBL] [Abstract][Full Text] [Related]
10. Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
Cinelli MA; Li H; Pensa AV; Kang S; Roman LJ; Martásek P; Poulos TL; Silverman RB
J Med Chem; 2015 Nov; 58(21):8694-712. PubMed ID: 26469213
[TBL] [Abstract][Full Text] [Related]
11. Progress in the development of selective nitric oxide synthase (NOS) inhibitors.
Salerno L; Sorrenti V; Di Giacomo C; Romeo G; Siracusa MA
Curr Pharm Des; 2002; 8(3):177-200. PubMed ID: 11812267
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of nitric oxide synthase by 1-(2-trifluoromethylphenyl) imidazole (TRIM) in vitro: antinociceptive and cardiovascular effects.
Handy RL; Harb HL; Wallace P; Gaffen Z; Whitehead KJ; Moore PK
Br J Pharmacol; 1996 Sep; 119(2):423-31. PubMed ID: 8886430
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.
Flinspach ML; Li H; Jamal J; Yang W; Huang H; Hah JM; Gómez-Vidal JA; Litzinger EA; Silverman RB; Poulos TL
Nat Struct Mol Biol; 2004 Jan; 11(1):54-9. PubMed ID: 14718923
[TBL] [Abstract][Full Text] [Related]
14. 2-Aminopyridines with a shortened amino sidechain as potent, selective, and highly permeable human neuronal nitric oxide synthase inhibitors.
Vasu D; Li H; Hardy CD; Poulos TL; Silverman RB
Bioorg Med Chem; 2022 Sep; 69():116878. PubMed ID: 35772285
[TBL] [Abstract][Full Text] [Related]
15. Potent, Selective, and Membrane Permeable 2-Amino-4-Substituted Pyridine-Based Neuronal Nitric Oxide Synthase Inhibitors.
Vasu D; Do HT; Li H; Hardy CD; Awasthi A; Poulos TL; Silverman RB
J Med Chem; 2023 Jul; 66(14):9934-9953. PubMed ID: 37433128
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline.
Furfine ES; Harmon MF; Paith JE; Knowles RG; Salter M; Kiff RJ; Duffy C; Hazelwood R; Oplinger JA; Garvey EP
J Biol Chem; 1994 Oct; 269(43):26677-83. PubMed ID: 7523410
[TBL] [Abstract][Full Text] [Related]
17. N5-(1-Imino-3-butenyl)-L-ornithine. A neuronal isoform selective mechanism-based inactivator of nitric oxide synthase.
Babu BR; Griffith OW
J Biol Chem; 1998 Apr; 273(15):8882-9. PubMed ID: 9535869
[TBL] [Abstract][Full Text] [Related]
18. Simplified 2-aminoquinoline-based scaffold for potent and selective neuronal nitric oxide synthase inhibition.
Cinelli MA; Li H; Chreifi G; Martásek P; Roman LJ; Poulos TL; Silverman RB
J Med Chem; 2014 Feb; 57(4):1513-30. PubMed ID: 24472039
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase and structure-based inhibitor design.
Poulos TL; Li H
Nitric Oxide; 2017 Feb; 63():68-77. PubMed ID: 27890696
[TBL] [Abstract][Full Text] [Related]
20. N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity.
Collins JL; Shearer BG; Oplinger JA; Lee S; Garvey EP; Salter M; Duffy C; Burnette TC; Furfine ES
J Med Chem; 1998 Jul; 41(15):2858-71. PubMed ID: 9667974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
